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Abstract. 
 
The mitogen-activated protein (MAP) ki-
nase pathway, which includes extracellular signal–regu-
lated protein kinases 1 and 2 (ERK1, ERK2) and MAP 
kinase kinases 1 and 2 (MKK1, MKK2), is well-known 
to be required for cell cycle progression from G1 to S 
phase, but its role in somatic cell mitosis has not been 
clearly established. We have examined the regulation 
of ERK and MKK in mammalian cells during mitosis 
using antibodies selective for active phosphorylated 
forms of these enzymes. In NIH 3T3 cells, both ERK 
and MKK are activated within the nucleus during early 
prophase; they localize to spindle poles between 
prophase and anaphase, and to the midbody during cy-
tokinesis. During metaphase, active ERK is localized in 
the chromosome periphery, in contrast to active MKK, 
which shows clear chromosome exclusion. Prophase ac-
tivation and spindle pole localization of active ERK 
 
and MKK are also observed in PtK
 
1
 
 cells. Discrete lo-
calization of active ERK at kinetochores is apparent by 
early prophase and during prometaphase with de-
creased staining on chromosomes aligned at the 
metaphase plate. The kinetochores of chromosomes 
displaced from the metaphase plate, or in microtubule-
disrupted cells, still react strongly with the active ERK 
antibody. This pattern resembles that reported for the 
3F3/2 monoclonal antibody, which recognizes a phos-
phoepitope that disappears with kinetochore attach-
ment to the spindles, and has been implicated in the mi-
totic checkpoint for anaphase onset (Gorbsky and 
Ricketts, 1993. 
 
J. Cell Biol
 
. 122:1311–1321). The 3F3/2 
reactivity of kinetochores on isolated chromosomes de-
creases after dephosphorylation with protein phos-
phatase, and then increases after subsequent phos-
phorylation by purified active ERK or active MKK. 
These results suggest that the MAP kinase pathway has 
multiple functions during mitosis, helping to promote 
mitotic entry as well as targeting proteins that mediate 
mitotic progression in response to kinetochore attach-
ment.
Key words: MAP kinase • mitosis • kinetochore • cell 
cycle • phosphorylation
 
G
 
rowth 
 
and differentiation factors regulate the mi-
togen-activated protein (MAP)
 
1
 
 extracellular sig-
nal–regulated protein kinases 1 and 2 (ERK1
and ERK2) through pathways using receptor tyrosine ki-
nases, cytokine receptors, and heterotrimeric G protein–
coupled receptors (Lewis et al., 1998; Robinson and Cobb,
1997). Activation occurs by coupling receptors to Ras,
Raf-1, and MAP kinase kinase-1 or -2 (MKK 1 or 2), the
latter of which activates ERK directly through phos-
phorylation. MKK is also phosphorylated and activated by
 
c
 
-mos, a germ cell–specific protein kinase that activates
the MKK/ERK pathway during meiotic cell division. ERK
functions as an essential regulator of cell growth and dif-
ferentiation in eukaryotic cells, so the identification of cel-
lular substrates for this enzyme is an important goal in elu-
cidating mechanisms for biological control.
The requirement for ERK in S phase entry is demon-
strated by a G1 arrest in cells where ERK activation is
blocked by expression of antisense constructs, dominant
negative mutants, dual specificity phosphatases, and treat-
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1. 
 
Abbreviations used in this paper
 
: APC, anaphase promoting complex;
DAPI, 4
 
9
 
,6-diamidino-2-phenylindole; ERK, extracellular signal–regu-
lated kinase; MAP, mitogen-activated protein; MKK, MAP kinase kinase;
MEKK, MAP/ERK kinase kinase; PP2A, protein phosphatase type 2A;
MPF, maturation promoting factor; NBF, neutral buffered formalin;
NTA, Ni
 
1
 
2
 
-nitrilotriacetic acid. 
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ment with the inhibitor of MKK1, PD98059 (Dudley et al.,
1995; Sun et al., 1993; Páges et al., 1993). ERK-regulated
events required for progression into S phase include ex-
pression of immediate early genes such as Fos and Egr-1,
and transcriptional upregulation of cyclin D1 (Lavoie et
al., 1996; Kortenjann et al., 1994; Beno et al., 1995). How-
ever, the function for ERK in mitosis is less well-defined.
The activations of 
 
c
 
-mos, MKK, and ERK play important
roles in inducing meiosis in oocytes (reviewed by Sagata,
1997), but ERK activity after fertilization declines and re-
mains low during mitotic cell division in early embryos
(Ferrell et al., 1991). Activation of ERK by 
 
c
 
-mos or injec-
tion of active ERK from unfertilized eggs in metaphase II
into two cell embryos induces cell cycle arrest, revealing a
cytostatic factor activity of this enzyme (Kosako et al., 1994;
Haccard et al., 1993). Likewise, adding active ERK to 
 
Xe-
nopus
 
 cell free extracts leads to arrest in G2 and suppres-
sion of cyclin B/cdc2 activation (Abrieu et al., 1997; Walter
et al., 1997). Taken together, these data suggest that ERK
functions positively during meiotic cell division, but in fact
negatively regulates mitotic progression in early embryos.
Consistent with results from early 
 
Xenopus
 
 embryos,
previous reports in somatic mammalian cells have shown
no activation of ERK during mitosis, as measured by SDS-
PAGE gel mobility retardation or in-gel phosphorylation
assays (Tamemoto et al., 1992; Edelmann et al., 1996). Ras
also appears to remain inactive during mitosis (Taylor and
Shalloway, 1996). Nevertheless, mitotic enhancement of
Raf-1 activity in cells synchronized by mitotic shake-off or
arrested with nocodazole has been reported (Laird et al.,
1995; Pathan et al., 1996), and inhibition of c-Src by anti-
body microinjection blocks mitotic entry (Roche et al.,
1995). These data indicate the existence of mitotic mecha-
nisms for activating ERK through known upstream path-
way components in somatic cells.
In this study, we examined the cellular localization of ac-
tive ERK and MKK during mitosis using antibodies that
specifically recognize active phosphorylated forms of
these enzymes. We report the novel finding that ERK and
MKK are activated early in prophase before nuclear enve-
lope breakdown, then becoming localized at spindle poles
later in prophase. Localization of ERK and MKK is not
entirely overlapping, in that active MKK is excluded from
condensed chromosomes, whereas active ERK associates
with kinetochores and within the chromosomal periphery
of condensed chromosomes. This result suggests that ERK
phosphorylation by MKK may be involved in chromo-
somal targeting. A functional role for ERK as a sensor or
effector for mitotic progression is suggested by correla-
tions between the appearance and disappearance of active
ERK at kinetochores, with those of the antigen(s) recog-
nized by the 3F3/2 monoclonal antibody. Previous studies
have shown that this antibody recognizes kinetochore
phosphoantigens that respond to spindle fiber attachment
(Gorbsky and Ricketts, 1993; Nicklas et al., 1995), and that
microinjection of 3F3/2 antibodies delays anaphase entry,
suggesting that the phosphoantigen is involved in regulat-
ing metaphase-to-anaphase transition (Campbell and Gorb-
sky, 1995). Our studies with isolated chromosomes indi-
cate that the 3F3/2 epitope is directly or indirectly
phosphorylated in response to ERK, suggesting novel
roles for ERK in somatic cell mitosis.
 
Materials and Methods
 
Antibodies, Enzyme Purification, and Immunoblotting
 
Affinity-purified rabbit polyclonal antibody to diphosphorylated ERK2
(anti-ACTIVE MAPK) was purchased from Promega Corp. (Madison,
WI), and mouse monoclonal antibody to diphosphorylated ERK2 was a
generous gift of Dr. Rony Seger (Yung et al., 1997). In experiments per-
formed to determine the specificity of the anti-ACTIVE MAPK antibody,
wild-type or mutant (His)
 
6
 
-rat ERK2 (Robbins et al., 1993) were ex-
pressed in bacteria, purified by Ni
 
1
 
2
 
-nitrilotriacetic acid (NTA) metal af-
finity chromatography (QIAGEN Inc., Valencia, CA), and phosphory-
lated for 10 min at 30
 
8
 
C with constitutively active mutant MKK1 (G1C:
 
D
 
N4/S218E/S222D; Mansour et al., 1996), which was expressed in bacteria
and purified as described (Mansour et al., 1994). Reactions contained 1 
 
m
 
g
ERK2, 1 
 
m
 
g MKK1, 0.1 mM ATP, 10 mM MgCl
 
2
 
, 20 mM Hepes, pH 7.4,
and 1 mM dithiothreitol in 25 
 
m
 
l. Alternatively, whole cell lysates were
prepared from NIH 3T3 cells starved in DMEM, 0% FBS overnight, and
then treated for 5 min with 10% serum and 0.1 
 
m
 
M PMA. Proteins were
separated by SDS-PAGE, transferred to Immobilon
 
 P 
 
(Millipore Corp.,
Bedford, MA), reacted with primary antibody (1:1,000 dilution, 1 h) fol-
lowed by 0.8 
 
m
 
g/ml goat anti–rabbit or mouse IgG (The Jackson Labora-
tories, Bar Harbor, ME) coupled to horseradish peroxidase, and then vi-
sualized by enhanced chemiluminiscence (Amersham Life Science, Inc.,
Arlington Heights, IL). Immunoblots were also probed using a rabbit
polyclonal antibody recognizing the COOH terminus of ERK2 (C-14;
Santa Cruz Biotechnology, Santa Cruz, CA).
Affinity-purified rabbit polyclonal antibody to phosphorylated MKK1/2
(anti-phosphoMEK1/2) was purchased from New England Biolabs Inc.
(Beverly, MA). To test its specificity, wild-type (His)
 
6
 
-human MKK1 was
expressed in bacteria, purified by Ni
 
1
 
2
 
-NTA affinity chromatography
(Mansour et al., 1996), proteolyzed with enterokinase (Invitrogen Corp.,
Carlsbad, CA), and phosphorylated with a constitutively active mutant of
MEK kinase ([His]
 
6
 
-MEKK
 
D
 
C; Khokhlatchev et al., 1996) for 3 h with 4
mM ATP, 15 mM MgCl
 
2
 
. This test resulted in monophosphorylated and
diphosphorylated forms of MKK1 that were subsequently resolved by
FPLC using a Mono Q HR5/5 column equilibrated in 20 mM Tris, pH 8,
10% (vol/vol) glycerol, 1 mM dithiothreitol, and were eluted with a linear
sodium chloride gradient in the same buffer. Mass spectrometric peptide
mapping and sequencing were performed using a PE Sciex API-III elec-
trospray ionization mass spectrometer (Resing and Ahn, 1998). This anal-
ysis revealed that the monophosphorylated form of MKK1 was modified
entirely at Ser218, indicating that phosphorylation by MEKK1 was or-
dered under these conditions. The diphosphorylated form of MKK1 was
modified entirely at Ser218 and Ser222. Immunoblotting using anti-phos-
pho-MEK1/2 antibody (1:1,000 dilution) was performed as above. Immu-
noblots were also probed with a rabbit polyclonal antibody recognizing
the NH
 
2
 
-terminus of MKK1 (C-18; Santa Cruz Biotechnology, Santa
Cruz, CA).
For experiments with intact chromosomes, wild-type (His)
 
6
 
-ERK2 or
catalytically inactive (His)
 
6
 
-ERK2(K52R) proteins were expressed in bac-
teria, purified by Ni
 
1
 
2
 
-NTA chromatography, and phosphorylated with
constitutively active mutant MKK1 (G7B: 
 
D
 
N4/S218D/S222D; Mansour
et al., 1996), which was expressed in bacteria and proteolyzed with entero-
kinase to remove the (His)
 
6
 
 tag. Reactions contained 170 
 
m
 
g ERK2, 15 
 
m
 
g
MKK1-G7B, 4 mM ATP, 15 mM MgCl
 
2
 
, 20 mM Hepes, pH 7.4, and 0.2%
(vol/vol) 
 
b
 
-mercaptoethanol in a final volume of 1 ml, and were incubated
for 3 h at 30
 
8
 
C. ERK2 was purified away from MKK and ATP by adsorp-
tion to Ni
 
1
 
2
 
-NTA resin incubated for 20 min at room temperature, fol-
lowed by three washes with 1 ml 10 mM Hepes, pH 7.4, 0.2% 
 
b
 
-mercap-
toethanol, and elution with 10 mM Tris pH 8, 0.3 M imidazole, 0.2%
 
b
 
-mercaptoethanol. Aliquots of the activated ERK2 were snap-frozen in
liquid nitrogen and stored at 
 
2
 
80
 
8
 
C. The reaction resulted in 
 
.
 
90%
diphosphorylation of ERK2 at Thr183 and Tyr185 as assessed by mass
spectrometric peptide mapping and sequencing. The specific activity of
the wild-type phosphorylated ERK2 was 1.5 
 
m
 
mol/min/mg, measured us-
ing 0.3 mg/ml myelin basic protein (Sigma Chemical Co., St. Louis, MO)
and 0.1 mM ATP as substrates (Mansour et al., 1994).
 
Cell Culture and Immunofluorescence Analysis of 
Fixed Cells
 
Mouse NIH 3T3, CHO, or rat kangaroo PtK
 
1
 
 cells were grown in DME-
supplemented with penicillin (100 U/ml), streptomycin (100 
 
m
 
g/ml), and 
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10% FBS (GIBCO-BRL, Gaithersburg, MD). In some experiments, cells
were treated with nocodazole (5 
 
m
 
g/ml), for 30 min before examination.
Cells were grown to 
 
z
 
75% confluence on round glass cover slips in 6-
or 10-cm plates. Cover slips were rapidly rinsed in cold (4
 
8
 
C) PBS, and
were then immediately fixed under one of the following conditions: (
 
a
 
)
glutaraldehyde fixation: samples were fixed with 0.1% (vol/vol) glutaral-
dehyde, 2% formaldehyde in PBS for 5 min, and were then permeabilized
with PBS, 0.1% Triton X-100 for 5 min; (
 
b
 
) neutral buffered formalin
(NBF)/methanol fixation: samples were fixed with 10% (vol/vol) NBF for
5 min, and were then permeabilized with cold (
 
2
 
20
 
8
 
C) 100% methanol
for 5 min; (
 
c
 
) paraformaldehyde fixation: samples were fixed with 4%
(vol/vol) paraformaldehyde for 5 min, and were then permeabilized with
PBS, 0.1% Triton X-100 for 5 min. After fixation in all cases, cells were in-
cubated in Tris-buffered saline (TBS, 50 mM Tris, pH 7.6, 0.15 M NaCl),
0.1% Tween 20, 3% BSA for 1 h. Coverslips were then incubated with pri-
mary antibody for 1 h, washed 4
 
3 
 
with TBS, 0.1% Tween 20, incubated
for 1 h with fluorescein isothiocyanate- or Texas Red–conjugated anti-
rabbit or anti-mouse secondary antibody (0.8 
 
m
 
g/ml, The Jackson Labora-
tories), washed 4
 
3 
 
with TBS, 0.1% Tween 20, and finally counterstained
with 4
 
9
 
,6-diamidino-2-phenylindole (DAPI, 0.4 
 
m
 
g/ml in PBS). Fluores-
cent images were viewed and photographed using a Zeiss Axioplan fluo-
rescence microscope with a Photometrics Sensys digital CCD camera sys-
tem. Images were manipulated using IP-LAB Spectrum software.
Controls for nonspecific staining were performed by preincubating pri-
mary antibody with 0.1 mg/ml diphosphorylated peptides CDPDHTG-
FLT(P)EY(P)VATRWYRA (used with antibody to phosphorylated
ERK) or CVSGQLIDS(P)MANS(P)FVGTRSY (used with antibody to
phosphorylated MKK), synthesized by Macromolecular Resources (Ft.
Collins, CO).
Other primary antibodies used in immunocytochemical studies include:
the mouse monoclonal antibody 3F3/2, which detects phosphorylated ki-
netochore epitopes (1:1,000 dilution; Cyert et al., 1988); a rabbit poly-
clonal antibody recognizing the kinetochore microtubule motor, CENP-E
(1:200 dilution; Yen et al., 1991); a mouse monoclonal antibody recogniz-
ing lamin B used to monitor nuclear membrane integrity (1:200 dilution;
Ab-1; Calbiochem-Novabiochem Corp., La Jolla, CA), and a mouse mono-
clonal antibody recognizing 
 
b
 
-tubulin (1:10 dilution) used to monitor spin-
dle pole location (Neighbors et al., 1988).
 
Purification, Immunostaining, and Analysis of
Isolated Chromosomes
 
Mitotic CHO chromosomes were isolated as described by Hyman and
Michison (1993, except that polyamines were omitted with no difference
in results), and stored at 
 
2
 
80
 
8
 
C in Pipes buffer (80 mM Pipes, pH 7, 1 mM
EGTA, 4 mM MgCl
 
2
 
, 5 mM dithiothreitol). Chromosomes were washed
by fivefold dilution into Pipes buffer containing 1 mM benzamidine, 1 
 
m
 
g/
ml aprotinin, and 0.5 
 
m
 
M phenylmethylsulfonyl fluoride, introduced into
perfusion chambers constructed by placing glass coverslips onto two strips
of cellophane tape (chamber volume 
 
z
 
10 
 
m
 
l), and allowed to settle by in-
cubation on ice for 10 min (Hunt and McIntosh, 1998).
For immunochemistry, chromosomes were blocked by introducing 20
 
m
 
l of 0.2 mg/ml BSA in Pipes buffer into the chamber and incubating for 2
min at room temperature. This was followed by 10 
 
m
 
l anti-ACTIVE ERK
rabbit polyclonal antibody (1:100 dilution in Pipes buffer) or 3F3/2 mono-
clonal antibody (1:1,000 dilution in Pipes buffer) containing 0.4 
 
m
 
g/ml
DAPI (2 min, room temperature). After two washes with 30 
 
m
 
l Pipes
buffer, 20 
 
m
 
l fluorescein isothiocyanate- or rhodamine-conjugated anti-
rabbit or anti-mouse secondary antibody (0.8 
 
m
 
g/ml) were introduced and
incubated for 2 min, followed by a final wash with 30 
 
m
 
l Pipes buffer.
Chambers were sealed with immersion oil, and observed directly without
fixation.
For experiments examining effects of ERK, MKK, or protein phos-
phatases on immunostaining, 20 
 
m
 
l (2 U) of protein phosphatase type 2A
catalytic subunit (PP2A; Promega Corp.) in Pipes buffer was introduced
into perfusion chambers and incubated for 15 min at room temperature.
This was followed by 20 
 
m
 
l Pipes buffer containing 2 
 
m
 
M microcystin (Al-
exis, Woburn, MA), and then 20 
 
m
 
l (2 
 
m
 
g) diphosphorylated ERK2-WT,
ERK2-K52R, or constitutively active mutant MKK1-G7B in 25 mM
Hepes, pH 7.4, 15 mM MgCl
 
2
 
, 2 mM ATP, 2 
 
m
 
M microcystin, 1 mM
dithiothreitol. Reactions were incubated for 10 min, and samples were
blocked and treated with primary and secondary antibodies as described
above. Control reactions were performed by adding microcystin to PP2A
before its addition to sample, or by omitting ERK or MKK from the sec-
ond reaction containing MgATP.
Samples were photographed by immunofluorescence microscopy as
above, using a 100
 
3
 
 objective, recording exposure times for each image.
Chromosomes were visualized under each condition, and the fluorescence
intensities of kinetochores were quantified by integrating absolute intensi-
ties within four pixel squares superimposed over the kinetochore pair.
Pixel intensities were corrected by subtracting an instrument baseline in-
tensity of 283 intensity units, determined by photographing a coverslip
coated with uranium at varying exposures, and extrapolating to zero expo-
sure time. Averages and standard errors of intensities are reported for
6–18 kinetochores as indicated.
 
Results
 
Wild-type ERK2 in different states of phosphorylation
and four of its mutant alleles were examined by immunob-
lotting in order to establish the specificity of the polyclonal
anti-ACTIVE MAPK antibody. Reactivity was observed
with either the wild type or with a catalytically inactive
mutant (K52R) after their phosphorylation with active
MKK1 (Fig. 1 
 
A
 
, lanes 
 
2
 
 and 
 
6
 
), but staining was com-
pletely absent with unphosphorylated ERK2 (Fig. 1 
 
A
 
,
lane 
 
1
 
). Reactivity was preferential for the diphosphor-
ylated enzyme, since monophosphorylated ERK2-Y185F
or -T183A mutants were poorly recognized by the anti-
body (Fig. 1 
 
A
 
, lanes 
 
4
 
 and 
 
5
 
). Interestingly, antibody reac-
tivity with monophosphorylated mutant ERK2-T183E was
nearly as efficient as with diphosphorylated ERK2-WT,
indicating the importance of a negative charge in epitope
recognition (Fig. 1 
 
A
 
, lane 
 
3
 
). Immunoblots of whole cell
extracts using the anti-ACTIVE MAPK antibody showed
elevated reactivity with ERKs 1 and 2 after stimulation of
NIH 3T3, CHO, or PtK
 
1
 
 cells with 10% serum/phorbol es-
ter, consistent with the expected protein kinase activation
(Fig. 1 
 
B
 
,
 
 top
 
). Importantly, no other proteins within the
extracts were strongly reactive, indicating specific recogni-
tion of ERKs among total cellular proteins. Comparable
loading of samples was shown by immunoreactivity of the
same cell extracts using a COOH-terminal ERK2 anti-
body (Fig. 1 
 
B
 
, 
 
bottom
 
).
Immunocytochemical staining of the anti-ACTIVE
MAPK antibody was examined in NIH 3T3 cells in various
stages of mitosis. Cells in interphase showed little or no re-
activity, but marked increases in active ERK staining were
observed in the nuclei of prophase cells identified by the
morphology of their chromatin (Fig. 2, 
 
A
 
 and 
 
G
 
). Costain-
ing of lamin B showed that the increased ERK reactivity
during prophase occurred before nuclear envelope break-
down (Fig. 3). Cells in metaphase showed a distinct local-
ization of active ERK to regions surrounding the con-
densed chromosomes (Fig. 2, 
 
B
 
 and 
 
H
 
). Close comparison
with DAPI staining indicated that active ERK staining
mainly occurred in regions surrounding chromatin, while
condensed chromosome arms were not as strongly reac-
tive. Staining of active ERK was also found at both spindle
poles (Fig. 2, 
 
H
 
 and 
 
I
 
) whose location was confirmed by
costaining with 
 
b
 
-tubulin antibodies (data not shown). In
anaphase, active ERK immunoreactivity was more dif-
fusely localized and largely excluded from chromosomes
(Fig. 2, 
 
C
 
 and 
 
I
 
). In telophase/cytokinesis, active ERK
appeared localized within cytoplasmic regions of both
daughter cells as well as the midbody (Fig. 2, 
 
D
 
 and 
 
J
 
).
The specificity of immunostaining was also tested by
preincubating the primary antibody with a diphosphory-
lated peptide corresponding to the phosphoepitope on 
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ERK. With phosphopeptide competition, active ERK im-
munoreactivity was undetectable in mitotic cells (Fig. 2, 
 
E
 
,
 
F
 
, 
 
K
 
, and 
 
L
 
). Immunoreactivity was also absent when the
primary antibody was omitted (data not shown). Experi-
Figure 1. Specificity of anti-ACTIVE MAPK antibody. (A) Im-
munoblots of wild type or mutant recombinant ERK2 phosphor-
ylated with constitutively active mutant MKK1-G1C. (Top) Im-
munoreactivity with anti-ACTIVE MAPK antibody. (Bottom)
Reactivity with antibody recognizing the COOH terminus of
ERK2, where ERK2 gel mobility is retarded upon phosphoryla-
tion. (B) Immunoblots of whole cell extracts (20 mg) from NIH
3T3, CHO, and PtK1 cells that were serum-depleted overnight,
and then treated with or without 10% serum 1 0.1 mM PMA for
5 min (PMA). (Top) Specific immunoreactivity of anti-ACTIVE
MAPK antibody with phosphorylated ERK1 and ERK2 (ar-
rows). Only phosphorylated ERK2 was observed in CHO cell ly-
sates. (Bottom) Corresponding levels of ERK2, probed with an
antibody recognizing the COOH terminus of ERK2. Filled ar-
rows show phosphorylated ERK2 with retarded mobility, and
open arrows show unphosphorylated ERK2.
Figure 2. Mitotic activation of ERK in NIH 3T3 cells. Cells were
fixed with glutaraldehyde, and were then stained with DAPI (A–
F) and anti-ACTIVE MAPK antibody probed with Texas Red–
conjugated secondary antibody (G–L). Fluorescence of represen-
tative cells in (A and G) interphase (upper cells) and prophase
(lower cell); (B and H) metaphase; (C and I) anaphase; and (D
and J) telophase are shown. Note active ERK staining at spindle
poles in metaphase and anaphase (H and I). Staining patterns
were reproduced with paraformaldehyde or NBF/methanol fixa-
tion. (E, F, K, and L) In peptide competition controls, anti-
ACTIVE MAPK antibody was preincubated with 0.1 mg/ml
phosphopeptide before incubation with coverslips. Under these
conditions, mitotic cells showed no ERK immunoreactivity, as
demonstrated with prophase (E and F) and metaphase (K and L)
cells.Shapiro et al. Activation of the MKK/ERK Pathway during Mitosis 1537
including 0.1% glutaraldehyde/2% formaldehyde, 4% para-
formaldehyde, or 10% neutral buffered formalin/metha-
nol. Identical results were observed in all cases (data not
shown), indicating that the cellular localization of active
ERK during mitosis is not a fixation artefact.
Localization of the upstream kinase, MKK, was exam-
ined using the anti-phospho-MEK1/2 antibody that is se-
lective for active forms of MKK1 and 2. The specificity of
this antibody was tested by immunoblotting MKK1 that
had been phosphorylated in vitro with MEKK1 and puri-
fied by Mono-Q FPLC. This antibody reacted with both
mono- and diphosphorylated MKK1, with preference for
the diphosphorylated form, while no reactivity was ob-
served with unphosphorylated MKK1 (Fig. 4 A, lanes
1–4). Monophosphorylated MKK1 has measurable activ-
ity that is z25% that of diphosphorylated enzyme (Resing
et al., 1995). Therefore, this antibody distinguishes be-
tween active and inactive forms of MKK. Unlike the anti-
ACTIVE ERK antibody, the anti-phospho-MEK1/2 anti-
body did not recognize a MKK mutant containing acidic
amino acid substitutions at phosphorylation sites (G1C;
Fig. 4 A, lane 4). Immunoblots of whole cell extracts
showed elevated reactivity with MKKs 1 and 2 after stimu-
lation of NIH 3T3, CHO, or PtK1 cells, but little or no re-
activity with other cellular proteins (Fig. 4 B, top). Whole
Figure 3. Activation of ERK
during prophase precedes nu-
clear envelope breakdown.
NIH 3T3 cells were fixed with
glutaraldehyde, and were
then stained with DAPI (A
and  D) and costained with (B
and E) anti-ACTIVE MAPK
antibodies probed with Texas
Red–coupled secondary anti-
bodies or (C and F) lamin B
antibodies probed with fluo-
rescein isothiocyanate-conju-
gated secondary antibodies.
Patterns of lamin B staining
indicate that nuclear enve-
lope membranes are intact in
prophase cells during ERK
activation. Corresponding in-
terphase cells are shown to
the left of each prophase cell
in the two representative im-
ages.
Figure 4. Specificity of anti-phosphoMEK1/2 antibody. (A) Im-
munoblots of wild-type or mutant recombinant MKK1, after
phosphorylation with constitutively active mutant MEKKDC.
(Top) Immunoreactivity with anti-phosphoMEK1/2 antibody.
(Bottom) Reactivity with antibody recognizing the NH2 terminus
of MKK1. Differences in gel mobility are a result of removing the
5-kD NH2 terminal (His)6 tag from mono- or diphosphorylated
MKK1, and deleting residues 44–51 in MKK1-G1C. (B) Immuno-
blots of whole cell extracts (20 mg) from NIH 3T3, CHO, and
PtK1 cells that were serum-depleted overnight, and then treated
with or without 10% serum 1 0.1 mM PMA for 30 min. (Top)
Specific immunoreactivity of anti-phosphoMEK1/2 antibody with
phosphorylated MKK1 and MKK2, indicated by arrows. (Bot-
tom) Corresponding levels of MKK1 probed with an antibody
recognizing the NH2 terminus of MKK1.
ments were also performed using a monoclonal antibody
to active diphosphorylated ERK, and showed identical
staining patterns (data not shown). Finally, experiments
were performed using three different fixation protocols,The Journal of Cell Biology, Volume 142, 1998 1538
cell extracts were also immunoblotted using an antibody
recognizing the NH2 terminus of MKK1 to demonstrate
comparable loading (Fig. 4 B, bottom).
Immunocytochemical staining of NIH 3T3 cells with the
anti-phosphoMEK1/2 antibody showed little reactivity
with interphase cells, but nuclear staining of active MKK
increased significantly during prophase (Fig. 5, A and G).
This result is notable because it represents the only case in
which nuclear localization of MKK has been observed un-
der normal cellular conditions without perturbing nuclear
export (Fukuda et al., 1996; Fukuda et al., 1997; Jaaro et
al., 1997). Like active ERK, localization of active MKK
was apparent at spindle poles during metaphase and
anaphase (Fig. 5, B, C, H, and I) and at the midbody dur-
ing telophase/cytokinesis (Fig. 5, D and J). Unlike active
ERK, however, active MKK appeared more diffusely lo-
calized throughout metaphase cells, and largely excluded
from chromosomes (Fig. 5, B and H). Antibody preincu-
bation with a diphosphorylated peptide corresponding to
the phosphoepitope on MKK1/2 eliminated staining of mi-
totic cells (Fig. 5, E, F, K, and L), supporting the specific-
ity of immunoreactivity with this antibody.
To visualize the nuclear localization of active ERK in
more detail, we examined PtK1 cells, which have fewer
chromosomes and a flatter morphology during mitosis. As
observed with NIH 3T3 cells, active ERK staining was ab-
sent in interphase PtK1 cells (data not shown), but in-
creased in nuclei during prophase (Fig. 6, A and B). Spin-
dle pole localization of active ERK was also observed
during prophase, before nuclear envelope breakdown
(Fig. 6 B). The higher resolution available from images of
PtK1 cells showed that much of the active ERK staining
was peripheral to prophase chromosomes. Furthermore, a
staining pattern of paired dots could be observed on each
prophase chromosome, suggesting a specific localization
of active ERK to kinetochores. This pattern was con-
firmed by colocalization of active ERK with the microtu-
bule motor CENP-E (Fig. 7, C and D), which localizes to
kinetochores in vivo (Yen et al., 1991). Inspection of cells
at different stages in prophase to prometaphase suggested
a temporal order of association: active ERK appears at ki-
netochores earlier in prophase than CENP-E, and leaves
the kinetochore earlier in metaphase/anaphase (Fig. 7).
The kinetochore localization of active ERK that was so
evident during prophase and prometaphase was more dif-
ficult to identify on chromosomes aligned at the meta-
phase plate, and was completely absent during anaphase
(Fig. 6, D and E, and Fig. 7 E). In contrast, CENP-E stain-
ing was still apparent at kinetochores during anaphase
(Fig. 7 F). These results suggest that either the phosphory-
lation or the targeting of ERK to this mechanically impor-
Figure 5. Mitotic activation of MKK in NIH 3T3 cells. Cells were
fixed with NBF/methanol, and were then stained with DAPI (A–
F) and anti-phosphoMEK1/2 antibody probed with Texas Red–
conjugated secondary antibody (F–L). Fluorescence of represen-
tative cells in (A and G) interphase and prophase; (B and H)
metaphase; (C and I) anaphase; and (D and J) telophase are
shown. Staining patterns were reproduced with paraformalde-
hyde or glutaraldehyde fixation. (E, F, K, and L) In peptide com-
petition controls, anti-phosphoMEK1/2 antibody was preincu-
bated with 0.1 mg/ml phosphopeptide before incubation with
coverslips. Under these conditions, mitotic cells showed no active
MKK immunoreactivity as demonstrated with prophase (E and
F) and metaphase (K and L) cells.Shapiro et al. Activation of the MKK/ERK Pathway during Mitosis 1539
tant region decreases as chromosomes separate. With
phosphopeptide competition, active ERK immunoreactiv-
ity was undetectable in mitotic PtK1 cells (data not
shown).
PtK1 staining was also examined using an antibody rec-
ognizing the COOH terminus of ERK2, which is not selec-
tive for the protein’s state of phosphorylation. An abun-
dance of total ERK2 was observed throughout PtK1 cells.
In interphase cells, ERK was primarily localized in cyto-
plasmic pools as previously reported (Lenormand et al.,
1993), but in prophase, nuclear staining increased signifi-
cantly, indicating the relocalization of a significant fraction
of the total ERK pool (Fig. 8). However, in contrast to ac-
tive ERK, kinetochore localization within the total pool of
nuclear ERK was masked, indicating that the active en-
zyme associating with kinetochores represents a small
fraction of total ERK.
Although kinetochore staining of active ERK was not
apparent in fixed and permeabilized NIH 3T3 cells (Fig.
2), we were also unable to observe CENP-E staining, indi-
cating that kinetochores were refractory to staining in
these experiments, perhaps due to cell shape. Consistent
with this finding, colocalization of active ERK and CENP-E
at kinetochores was observed in porcine kidney epithelial
LLCPK1 cells, which also exhibit a flat morphology during
mitosis (data not shown). As noted below, kinetochore lo-
calization of active ERK was also observed on isolated
chromosomes from NIH 3T3 cells, CHO cells, and 9948
human lymphoblasts. Active ERK localized to kinetochores
of every cell type we examined, indicating that it repre-
sents a general phenomenon in mammalian cells.
Examination of phospho-MKK in PtK1 cells also showed
increased nuclear staining during prophase, with spindle
pole localization during prophase to anaphase, and was
mostly excluded from chromosome arms (Fig. 9, A–D).
Figure 6. Mitotic activation of ERK in PtK1 cells. Cells were
fixed with glutaraldehyde, and were then stained with DAPI and
anti-ACTIVE MAPK antibody probed with Texas Red–conju-
gated secondary antibody. Fluorescence of representative cells in
(A) early prophase; (B) late prophase; (C) prometaphase; (D)
metaphase; (E) anaphase; and (F) telophase. Interphase cells are
also shown in E and F. Staining patterns were also reproduced
with paraformaldehyde or NBF/methanol fixation. Controls
show no immunoreactivity when anti-ACTIVE MAPK antibody
was preincubated with 0.1 mg/ml phosphopeptide before incuba-
tion with coverslips (data not shown).
Figure 7. Active ERK and CENP/E colocalize at kinetochores. PtK1
cells were fixed with glutaraldehyde, and were then stained with
DAPI together with mouse monoclonal anti-phosphoMAPK an-
tibody and rabbit anti-CENP-E antibody, probed with Texas
Red– or fluorescein isothiocyanate–conjugated secondary anti-
bodies, respectively. Fluorescence of representative cells in (A
and B) prophase; (C and D) prometaphase; and (E and F)
anaphase; showing kinetochore staining of active ERK early in
prophase, before the appearance of CENP-E, and disappearance
of kinetochore-associated active ERK during anaphase before
the disappearance of CENP-E. An interphase cell is also shown
in E and F.The Journal of Cell Biology, Volume 142, 1998 1540
In general, phospho-MKK showed infrequent reactivity
with kinetochores compared with phospho-ERK, although
paired dot patterns were evident in some cases (Fig. 9 B).
These data indicate that active ERK and active MKK ac-
cumulate in nuclei during prophase, and suggest that ac-
tive ERK might preferentially associate with kinetochores.
These results suggest that ERK phosphorylation might
serve as a signal for chromosome targeting.
Indeed, the temporal pattern of phosphoERK associa-
tion with kinetochores is similar to that observed using
3F3/2, a monoclonal antibody raised to crude maturation
promoting factor (MPF) preparations that recognizes nu-
clear phosphorylated antigens (Cyert et al., 1988; Gorbsky
and Ricketts, 1993). Kinetochore phosphoepitopes have
been shown to react with this antibody under conditions
where chromosomes are misaligned or detached from mi-
crotubules, suggesting that the decreases in antigen reac-
tivity that occur during mitotic progression are caused by
dephosphorylation as the chromosomes align under mi-
crotubule-induced tension at the metaphase plate (Gorb-
sky and Ricketts, 1993; Nicklas et al., 1995).
Temporal correlations in mitotic localizations of active
ERK and the 3F3/2 phosphoepitope were observed by
double immunofluorescence staining of PtK1 cells. Kinet-
ochore colocalization of both antigens was apparent from
early prophase through prometaphase (Fig. 10, A–D). In
metaphase cells, partial kinetochore staining could some-
times be observed with anti-ACTIVE MAPK antibody,
but never with 3F3/2 antibody (Fig. 10, E and F), suggest-
ing that the dephosphorylation of the 3F3/2 antigen during
metaphase precedes inactivation of ERK. In both cases,
kinetochore staining was absent on chromosomes in
anaphase (data not shown). The dependence of kineto-
Figure 8. Active ERK localized to kinetochores is a minor frac-
tion of the total ERK pool. PtK1 cells were fixed with glutaralde-
hyde, and were then stained with (A) COOH-terminal ERK2 an-
tibody probed with Texas Red–conjugated secondary antibody;
or (B) DAPI. Fluorescence of representative cells in prophase
and interphase are shown in each panel. Although a significant
percentage of ERK is nuclear in prophase, kinetochore localiza-
tion cannot be detected.
Figure 9. Mitotic activation of MKK in PtK1 cells. Cells were
fixed with glutaraldehyde, and were then stained with DAPI and
anti-phosphoMEK1/2 antibody probed with Texas Red–conju-
gated secondary antibody. Fluorescence of representative cells in
(A) prophase; (B) prometaphase; (C) metaphase; and (D)
anaphase. Staining patterns were reproduced with paraformalde-
hyde or NBF/methanol fixation. Controls show no immunoreac-
tivity when anti-phosphoMEK1/2 antibody was preincubated
with 0.1 mg/ml phosphopeptide before incubation with coverslips
(data not shown).
Figure 10. Active ERK and 3F3/2 antigen colocalize at kineto-
chores. PtK1 cells were fixed with glutaraldehyde, and were then
stained with DAPI, together with anti-ACTIVE MAPK antibody
probed with Texas Red–coupled secondary antibody and 3F3/2
antibody probed with fluorescein isothiocyanate-conjugated sec-
ondary antibody. Fluorescence of representative cells in (A and
B) prophase; (C and D) prometaphase; and (E and F) metaphase,
showing corresponding appearances of active ERK and 3F3/2 an-
tigen at kinetochores early in prophase, and disappearance at or
after metaphase.Shapiro et al. Activation of the MKK/ERK Pathway during Mitosis 1541
chore localization of active ERK on microtubule attach-
ment was also examined. Treatment of cells with nocoda-
zole to disrupt spindle microtubules resulted in stabilized
kinetochore localization of active ERK as well as the 3F3/2
antigen (Fig. 11, A and B). Untreated metaphase cells
were inspected for chromosomes that were aberrantly dis-
placed from the metaphase plate, which is easily identifi-
able by DAPI staining. In several such examples, kineto-
chores on displaced chromosomes showed significantly
enhanced staining with anti-ACTIVE MAPK antibody
compared with the reduced staining of aligned chromo-
somes (Fig. 11, C and D). Thus, the activity of ERKs
bound to kinetochores appears to correlate inversely with
kinetochore-microtubule attachments, consistent with the
behavior of the 3F3/2 phosphoantigen, as reported previ-
ously (Gorbsky and Ricketts, 1993; Nicklas et al., 1995).
To explore a possible functional relationship between
active ERK and the 3F3/2 antigen, chromosomes were iso-
lated from CHO cells, immobilized on coverslips within
perfusion chambers, and visualized by immunofluores-
cence. Both active ERK and 3F3/2 reactive antigens were
observed at kinetochores (Fig. 12, A and B). Staining on
chromosome arms was visible, but low compared with ki-
netochore staining, indicating that the most stable associa-
tion is at the kinetochores. Similar results were observed
with isolated chromosomes from NIH 3T3 cells or 9948
lymphoblasts (data not shown). After perfusion with PP2A,
the fluorescence staining for 3F3/2 antigens at kineto-
chores of CHO cells was dramatically decreased (Fig. 12
C). At least some of this activity returned after treating
phosphatase-treated chromosomes with microcystin, ac-
tive diphosphorylated ERK2, and Mg/ATP (Fig. 12 D).
These results motivated an optical quantification of
epitope levels after various experimental treatments.
Quantitative measurements showed decreased staining of
kinetochores with anti-ACTIVE MAPK antibody in re-
sponse to phosphatase treatment (Fig. 13 A), conditions
where dephosphorylation of ERK would be expected. In
addition, the fluorescence intensity of 3F3/2 antibody
staining at kinetochores decreased by 75% after 15 min of
reaction with PP2A (Fig. 13, B and C), as compared with
controls in which PP2A was omitted or dephosphorylation
was blocked with microcystin (Fig. 13, B and C). This re-
sult is consistent with the proposed recognition of a phos-
phorylated epitope by the 3F3/2 antibody (Cyert et al.,
1988; Gorbsky and Ricketts, 1993).
After PP2A treatment, microcystin was added to block
dephosphorylation, and purified diphosphorylated ERK2
was perfused into chambers along with MgATP. In this
case, the fluorescence intensity of 3F3/2 staining increased
by four to fivefold after 10 min of reaction with wild-type
active ERK2 (Fig. 13, B and C). The staining also in-
creased by about twofold when chromosomes were per-
fused with MgATP alone, or when perfused with MgATP
in presence of diphosphorylated, catalytically inactive mu-
tant ERK2-K52R. Furthermore, perfusion of chromo-
somes with constitutively active mutant MKK1-G7B in the
Figure 11. Kinetochore localization of active ERK correlates
with microtubule disruption or chromosome displacement. (A
and B) PtK1 cells were treated with nocodazole for 30 min, and
were then fixed with glutaraldehyde and stained with DAPI, anti-
ACTIVE MAPK antibody, and 3F3/2 antibody as in Fig. 10. Flu-
orescence of representative cells in metaphase showed stable ki-
netochore staining of (A) active ERK and (B) 3F3/2 antigen. (C
and D) Untreated PtK1 cells fixed and stained with DAPI or anti-
ACTIVE MAPK antibody. High immunoreactivity of active
ERK is observed on metaphase chromosomes that are misaligned
from the metaphase plate.
Figure 12. Kinetochore localization of active ERK and 3F3/2 an-
tigen on isolated chromosomes. (A and B) Isolated CHO cell
chromosomes bound to glass coverslips were stained without fix-
ation with DAPI and (A) anti-ACTIVE MAPK antibody or (B)
3F3/2 antibody, probed in each case with Texas Red–conjugated
secondary antibodies. (C and D) Isolated chromosomes were in-
cubated with added (C) PP2A for 15 min, or (D) PP2A for 15
min, followed by 2 mM microcystin, 2 mg active ERK2, and
MgATP for 10 min. Chromosomes were then stained with DAPI
and 3F3/2 antibody, followed immediately by data collection.The Journal of Cell Biology, Volume 142, 1998 1542
presence of MgATP after PP2A treatment led to a signifi-
cant increase in 3F3/2 staining at kinetochores compared
with perfusion with MgATP alone (Fig. 13 D).
Immunoblotting of active ERK showed no reactivity
with 3F3/2 antibody (data not shown), indicating that
diphosphorylated ERK is not likely to be the 3F3/2 reac-
tive phosphoantigen. Taken together, our results are con-
sistent with a model in which the 3F3/2 antigen can be
phosphorylated in response to addition of exogeneous
ERK2, as well as by endogenous protein kinases located at
kinetochores, possibly including ERK2. These findings in-
dicate that the 3F3/2 phosphoepitope may be regulated by
ERK, suggesting a role for ERK function at kinetochores
in mediating responses to the microtubule attachments
that control anaphase onset.
Discussion
The results presented above suggest that active forms of
both ERK and MKK become concentrated in the pro-
phase nuclei of somatic mammalian cells. ERK is localized
particularly to the kinetochores of the condensing chro-
mosomes. Centrosomal staining is also seen with both an-
tigens. It becomes clear at prometaphase and is main-
tained through anaphase, but the strength of ERK
localization at kinetochores decreases as the chromo-
somes attach to the spindle and become organized at the
metaphase plate. This behavior is reminiscent of the stain-
ing seen with 3F3/2, a monoclonal antibody that recog-
nizes a phosphoepitope found on mature but unattached
chromosomes. The intensity of 3F3/2 staining of kineto-
chores on isolated mammalian chromosomes treated with
phosphatases and kinases is consistent with the hypothesis
that ERK contributes to the formation of the 3F3/2
epitope, and therefore may play a role in regulating ki-
netochore function during mitosis.
Our results with antibodies selective for the active phos-
phorylated forms of ERK and MKK demonstrate signi-
ficant increases in the specific localizations of the en-
dogeneous enzymes during mammalian cell mitosis. The
concentration of these enzymes in nuclei during early
prophase of cycling somatic cells supports a role for the
MAP kinase pathway in regulating early mitotic events.
This result was unexpected because previous biochemical
studies of kinase activity measured by SDS-PAGE gel mo-
bility retardation or in-gel phosphorylation assays of mam-
malian cell extracts failed to show ERK activation during
mitosis (Tamemoto et al., 1992; Edelmann et al., 1996).
These differences can be reconciled by comparing the
staining patterns seen with the anti-ACTIVE MAPK anti-
body versus staining with an antibody recognizing both
unphosphorylated and phosphorylated ERK. The mitoti-
cally active pool of ERK appearing at discrete mitotic lo-
cations represents a minor fraction of the total ERK, and
thus may not be observable by examining bulk kinase ac-
tivity. This highlights the key advantage of antibodies that
selectively recognize active phosphorylated forms of regu-
latable enzymes for studies of cell process control.
A requirement for ERK in M phase entry has been ex-
tensively studied in several model systems for meiotic cell
division (reviewed by Yew et al., 1994; Sagata, 1997). Dur-
ing oocyte maturation, ERK activation promotes release
from G2 arrest and entry into metaphase I. In dividing so-
matic cells, activation of ERK by active mutant MKK ex-
pression enhances cell growth rate, consistent with a role
in promoting cell cycle progression (Seger et al., 1994).
Significantly, recent findings suggest a requirement for
MKK and ERK during the G2-M transition in cycling
mammalian cells (J.H. Wright and E.G. Krebs, personal
communication). In these studies, synchronized NIH 3T3
cells allowed to progress through S phase were retarded in
M phase entry after inhibition of MKK/ERK with a do-
minant negative mutant MKK1 or the MKK1 inhibitor,
PD98059. Under these conditions, tyrosine dephosphory-
lation of cdc2 was suppressed, indicating that MKK/ERK
is somehow involved in mitotic entry upstream of cyclin
B/cdc2 activation. These findings are consistent with our
results showing that MKK and ERK are activated early in
prophase before nuclear envelope breakdown.
ERK also prevents release from metaphase II arrest in
oocytes through inhibition of cyclin B degradation and sta-
Figure 13. Sensitivity of active ERK or 3F3/2 antigen at isolated
kinetochores to dephosphorylation or rephosphorylation by
added enzymes. (A) Isolated chromosome samples bound to
glass coverslips were incubated without or with PP2A (2U) for 15
min, followed by staining with DAPI and anti-ACTIVE MAPK
antibody, as in Fig. 12. 8–14 kinetochores were examined for each
condition. (B) Chromosomes were incubated without or with
PP2A for 15 min, with PP2A followed by 2 mM microcystin, 2 mg
active ERK2, and MgATP, or with PP2A followed by microcys-
tin and MgATP for 10 min. 12–18 kinetochores were examined
for each condition. (C) Chromosomes were incubated with
PP2A1microcystin for 15 min, with PP2A for 15 min minus in-
hibitor, with PP2A for 15 min followed by microcystin, active
ERK2, and MgATP, or with PP2A for 15 min followed by micro-
cystin, diphosphorylated catalytically inactive ERK2-K52R, and
MgATP. 6–9 kinetochores were examined for each condition.
(D) Chromosomes were incubated with PP2A for 15 min minus
inhibitor followed by microcystin and MgATP or microcystin, ac-
tive MKK1-G7B, and MgATP for 15 min. Eight kinetochores
were examined for each condition. Average fluorescence intensi-
ties and standard errors are shown, normalized to controls in
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bilization of cdc2 activity (Sagata, 1997). Injection of Mos,
active MKK, or active ERK into two-cell frog embryos in-
duces a similar M phase arrest with elevated cyclin B/cdc2
activity (Haccard et al., 1993; Kosako et al., 1994). Similar
findings were reported in frog embryo extracts, where G2
arrest as well as M phase arrest were observed in response
to Mos, MKK, or ERK, depending on the timing of addi-
tion (Abrieu et al., 1997; Walter et al., 1997). These results
may be important in understanding ERK and mechanisms
for spindle checkpoint regulation, given that mitotic frog
extracts undergo metaphase arrest when challenged with
high levels of sperm DNA together with microtubule-
destabilizing agents in a manner that depends upon ele-
vated ERK activity and stabilization of cyclin B/cdc2 activ-
ity (Minshull et al., 1994; Takenaka et al., 1997). These
data suggest that ERK promotes metaphase spindle
checkpoint arrest by interfering with the activation of the
anaphase-promoting complex (APC), perhaps by func-
tioning upstream or in parallel with other checkpoint regu-
latory pathways (Abrieu et al., 1996).
The kinetochore localization of active ERK that we ob-
serve in PtK1 cells suggests a mechanism by which ERK
might regulate anaphase entry. Previous findings indicate
that microtubule tension on chromosomes and kineto-
chore attachment is an important feature of the mitotic
checkpoint regulating anaphase entry (reviewed by Nick-
las, 1997). In particular, it has been suggested that domi-
nant signals derived from unattached kinetochores may
delay anaphase entry (McIntosh, 1991). Such signals may
involve phosphorylation of proteins within pathways that
regulate APC activation and cyclin B degradation, which
are required for the metaphase-to-anaphase transition
(Gorbsky, 1997; Nigg et al., 1996). A useful probe for
phosphorylation signals has been the 3F3/2 monoclonal
antibody, originally raised to impure MPF preparations,
which appears to recognize phosphorylated antigens lo-
cated at kinetochores. Reactivity with kinetochores is high
during prophase and prometaphase, and appears to dimin-
ish during metaphase as microtubules attach. On the other
hand, reactivity increases during kinetochore detachment,
and loss of tension induced in response to nocodazole or
by physical misalignment of chromosomes away from the
metaphase plate (Gorbsky and Ricketts, 1993; Nicklas et
al., 1995). Furthermore, 3F3/2 antibody microinjection
into cycling cells delays anaphase onset, suggesting that
dephosphorylation of this antigen is a necessary event for
chromosome segregation (Campbell and Gorbsky, 1995).
We observed that the appearance and disappearance of
active ERK at kinetochores resembled the timing and be-
havior of 3F3/2 immunoreactivity previously reported,
suggesting that regulation of ERK may be linked somehow
to 3F3/2 antigen phosphorylation. Active ERK appeared at
kinetochores during prophase and prometaphase and
disappeared at some point during the metaphase-to-
anaphase transition. Furthermore, stable kinetochore stain-
ing was observed under conditions of microtubule disrup-
tion or on chromosomes that were displaced from the
metaphase plate. Isolated chromosomes provided an ex-
cellent model system to test whether kinetochore 3F3/2
antigens could be modulated by ERK activity, allowing
quantification of immunostaining after direct reactions
with added enzymes. Interestingly, both active ERK and
the 3F3/2 antigen were present on kinetochores, indicat-
ing a stable association of these antigens with isolated
chromosomes. Reduced staining of each was observed
after protein phosphatase treatment, most likely due to
phosphoepitope dephosphorylation. Importantly, the en-
hanced reactivity of kinetochores with 3F3/2 antibody af-
ter incubation with active ERK2 or active MKK1 indicates
that 3F3/2 antigen(s) are likely to be targets for ERK or
ERK-regulated kinases. The only known substrates for
MKK1 are ERKs 1 and 2, suggesting that the 3F3/2 anti-
gen is phosphorylated by ERK or an ERK-regulated ki-
nase, endogeneously localized at kinetochores. It is there-
fore reasonable that ERK in its active form might serve as
a signal at kinetochores, allowing cells to sense improper
chromosome attachment to spindle microtubules via phos-
phorylation of the 3F3/2 antigen. Dephosphorylation of
the 3F3/2 antigen after microtubule attachment and result-
ing increased tension at kinetochores might then release
the inhibitory checkpoint machinery, facilitating APC acti-
vation and protein degradation events needed for ana-
phase entry.
Other MAP kinase signaling pathways may also be in-
volved in M-phase progression. The p38 MAPK has been
implicated in spindle assembly checkpoint and mitotic ar-
rest in mammalian cells (Takenaka et al., 1998), based on
data reporting the activation of p38 MAPK during no-
codazole-induced mitotic arrest and partial suppression of
the nocodazole-induced checkpoint by a p38 MAPK in-
hibitor. So far we have found no evidence for p38 MAPK
activation in mitotic cells, localization of active enzyme at
kinetochores of permeabilized cells, or isolated chromo-
somes using an antibody from New England Biolabs (Bev-
erly, MA) that recognizes active, diphosphorylated p38
MAPK (data not shown). The specificity of this antibody
was confirmed by enhanced immunofluorescence of per-
meabilized cells or reactivity in immunoblots of cells ex-
posed to UV irradiation (data not shown). Therefore, p38
MAPK is probably not involved in 3F3/2 antigen phosphor-
ylation.
Another important result from our study is the localiza-
tion of active ERK at the chromosome periphery during
prophase and prometaphase, as well as at spindle poles
during prophase, metaphase, and anaphase. The pattern of
active ERK on spindle microtubules, spindle poles, and ki-
netochores suggests a role of ERK in regulating spindle
assembly, possibly through regulation of motor activity or
microtubule polymerization. Spindle pole immunostaining
was previously reported during meiotic metaphase in
mouse oocytes and mitosis in Xenopus tadpole cells (Verl-
hac et al., 1993; Wang et al., 1997). ERK staining of micro-
tubules has also been observed in NIH 3T3 cells, though it
is somewhat dependent on the antibody used (Rezka et
al., 1995), and association of active and inactive ERK
pools with tubulin and MAPs has been demonstrated bio-
chemically (Morishima-Kawashima and Kosik, 1996; Man-
delkow et al., 1992). Furthermore, adding active MAPK to
interphase frog embryo extracts leads to microtubule
shortening and organization, which resembles a mitotic ar-
ray (Gotoh et al., 1991). Potential mediators of microtu-
bule depolymerization include MAPs such as tau, which,
upon phosphorylation by ERK enhances the probability
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Hoshi et al., 1992; Dreschsel et al., 1992). Another possible
target is stathmin/Op18, which facilitates microtubule ca-
tastrophe and mitotic destabilization of interphase micro-
tubules (Belmont and Mitchison, 1996), and is hyperphos-
phorylated during mitosis at sites targeted by several
kinases, including ERK (Brattsand et al., 1994; Marklund
et al., 1993; Larsson et al., 1995).
In summary, current data suggest that the MKK/ERK
pathway plays multiple roles during mitosis, promoting
critical events that regulate mitotic entry or spindle assem-
bly and function, as well as inhibiting events needed for
anaphase entry. Our findings raise new questions about
downstream targets for ERK at different stages of mitotic
progression, and the potential overlap in specificity be-
tween ERK and cyclin B/cdc2 for substrates. Further ques-
tions are also raised regarding the mechanism of MKK
and ERK activation in G2. It is reasonable to suggest that
this regulatory pathway involves at least some of the com-
ponents identified as upstream regulators in G1. The mi-
totic activation of MKK and its requirement for mitotic
entry in NIH 3T3 cells (J.H. Wright and E.G. Krebs, per-
sonal communication) is consistent with previous reports
of mitotic activation of Src and Raf as well as a require-
ment for Src activation during M phase entry (Roche et
al., 1995; Laird et al., 1995). At this time, no evidence ex-
ists for a mitotic role for Ras that may explain Src or Raf
regulation. Therefore, the possibility exists that alternative
mechanisms, perhaps involving novel upstream regulators
of the MAPK pathway, function to control M phase entry.
Finally, an important event revealed in our studies is the
nuclear uptake of both MKK and ERK during prophase,
before nuclear envelope breakdown. Although previous
work has demonstrated ERK translocation after activa-
tion in response to growth factors (Lenormand, 1993), nu-
clear localization of MKK has been demonstrated only
with MKK mutants lacking its nuclear export signal or un-
der conditions where nuclear export is inhibited (Fukuda,
1996; Fukuda, 1997; Jaaro et al., 1997). Localization of ac-
tive MKK during prophase identifies a unique physiologi-
cal condition where nuclear uptake is favored, and speci-
fies an important function of regulatory mechanisms for
nuclear import during cell cycle progression.
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